About the Eversense E3 CGM System
The Eversense E3 CGM System is designed for adults with type 1 or type 2 diabetes on insulin. It provides 6 months of continuous glucose readings, reducing interruptions in CGM care. The system has a high sensor survivability rate, with 95% of sensors surviving the full 6 months.
Key Features
The Eversense E3 system delivers accurate readings with only 1 day of calibration, has most accurate readings in low glucose ranges, and provides dependable detection alerts. It also has minimal skin reactions from adhesive and is easy to use.
For further information, please refer to the user guide or visit https://www.ascensiadiabetes.com/eversense-safety-info.
Manual:
Download: Eversense E3 Continuous Glucose Monitoring System User Guide
Chat: Powered By VoiceSphere